Interactions of cisplatin and transplatin with proteins
- 15 January 2002
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 91 (1) , 306-311
- https://doi.org/10.1016/s0162-0134(02)00362-8
Abstract
No abstract availableKeywords
Funding Information
- Israel Cancer Association (20010031-B)
This publication has 25 references indexed in Scilit:
- Recognition of cisplatin adducts by cellular proteinsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
- Current status of trans-platinum compounds in cancer therapyCoordination Chemistry Reviews, 2001
- Current status of the development of trans-platinum antitumor drugsCritical Reviews in Oncology/Hematology, 2000
- Why Does Cisplatin Reach Guanine-N7 with Competing S-Donor Ligands Available in the Cell?Chemical Reviews, 1999
- Structure, Recognition, and Processing of Cisplatin−DNA AdductsChemical Reviews, 1999
- Donor atom preferences in complexes of platinum and palladium with amino acids and related moleculesCoordination Chemistry Reviews, 1997
- Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatinNature, 1995
- Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancerLung Cancer, 1995
- Phase I trial of a cisplatin‐albumin complex for the treatment of cancer of the head and neck.British Journal of Clinical Pharmacology, 1992
- Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusionCancer Chemotherapy and Pharmacology, 1980